A detailed history of Abound Wealth Management transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Abound Wealth Management holds 4 shares of AMPH stock, worth $193. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Previous 6 33.33%
Holding current value
$193
Previous $240,000 18.75%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$36.99 - $50.09 $73 - $100
-2 Reduced 33.33%
4 $195,000
Q2 2023

Aug 08, 2024

BUY
$35.77 - $58.38 $214 - $350
6 New
6 $345,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.37B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Abound Wealth Management Portfolio

Follow Abound Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abound Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Abound Wealth Management with notifications on news.